TherapeuticsMD, Inc., parent company of vitaMedMD, LLC, announced it launched vitaMedMD Iron 21/7, an over-the-counter, patient-friendly, daily iron supplement.
(PRWeb July 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9704509.htm
• GENETRIX's first global licensing agreement • Commercial validation of X-Pol Biotech's Qualiphi polymerase technology • High commercial relevance for X-Pol and GENETRIX
(PRWeb July 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9703141.htm
MDDX creates hands-on course designed to increase proficiency of entire medical team performing TAVR
(PRWeb July 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9706188.htm
The Reproductive Science Center of New England, a fertility center based in Lexington, MA, has the highest rate of singleton births (79%) in Massachusetts, New Hampshire and Rhode Island according to...
(PRWeb July 17, 2012)
Read the full story at http://www.prweb.com/releases/2012Singletonvsmultiples/07/prweb9703452.htm
“This grant supports an important new opportunity for patients with Grade 3 glioma,” said Al Musella, DPM, President of the Musella Foundation. “It is innovations like Toca 511 & Toca FC that we...
(PRWeb July 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9702371.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments